William Blair Starts LogicBio Therapeutics (LOGC) at Outperform
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
6 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
William Blair analyst Raju Prasad initiates coverage on LogicBio Therapeutics (NASDAQ: LOGC) with a Outperform rating.
For an analyst ratings summary and ratings history on LogicBio Therapeutics click here. For more ratings news on LogicBio Therapeutics click here.
Shares of LogicBio Therapeutics closed at $13.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
- BofA Securities Resumes Williams-Sonoma (WSM) at Buy
- Nomura/Instinet Starts Compeq Manufacturing (2313:TT) (SHZHY) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
